Compare SBET & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SBET | TNDM |
|---|---|---|
| Founded | 1995 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.4B |
| IPO Year | 2025 | 2013 |
| Metric | SBET | TNDM |
|---|---|---|
| Price | $8.23 | $22.28 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 19 |
| Target Price | $18.71 | ★ $28.00 |
| AVG Volume (30 Days) | ★ 8.1M | 2.2M |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $28,055,000.00 | ★ $1,014,736,000.00 |
| Revenue This Year | $105.19 | $8.11 |
| Revenue Next Year | $13.53 | $11.85 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 666.04 | 7.93 |
| 52 Week Low | $4.46 | $11.46 |
| 52 Week High | $20.27 | $29.65 |
| Indicator | SBET | TNDM |
|---|---|---|
| Relative Strength Index (RSI) | 75.66 | 59.90 |
| Support Level | $6.05 | $21.71 |
| Resistance Level | $10.91 | $24.23 |
| Average True Range (ATR) | 0.36 | 1.44 |
| MACD | 0.18 | -0.10 |
| Stochastic Oscillator | 88.42 | 66.93 |
Sharplink Inc is one of those publicly traded companies to adopt ETH as its primary treasury reserve asset. This move reflects the Company's commitment to align corporate treasury with the future of programmable finance, digital capital markets, and decentralized infrastructure. The Company also operates an online affiliate marketing company that delivers different fan activation solutions to its sportsbook and online casino gaming partners. The company operates in two reportable segments: ETH Treasury Management and Affiliate Marketing. The majority of its revenue is generated from the ETH Treasury Management. Geographically, the company operates in the United States and the rest of the world.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.